Samaha Eli's Form 4 filing
Theravance Biopharma, Inc. (TBPH) · filed Jul 8, 2026
- Accession no.
- 0001877589-26-000002
- Filed
- Jul 8, 2026, 4:13 PM ET
- Trade date
- Jul 6-7, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $119.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Samaha EliCIK 0001877589 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 6, 2026 | COM | SSaleDisposed | −1,400 | $17.04 | −$23,856 | 9,173,053 | Indirect | |
| Jul 7, 2026 | COM | SSaleDisposed | −5,564 | $17.17 | −$95,540.56 | 9,167,489 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.